Skip to content
What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock Record artwork

What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock Record

WSJ What’s News

January 17, 2026

Why are investors buzzing about Novo Nordisk’s Wegovy pill launch? And how has sentiment turned against software makers like Salesforce? Plus, what drove BlackRock’s asset pile to a record $14 trillion? Host Jack Pitcher discusses the biggest stock moves of the week and the news that drove them.

Speakers Jack Pitcher

TopicsDaily NewsNews

SPEAKER_1 (0:00)

AI is here and Chevron is working to power it. We're aiming to develop multi-gigawatt power plants near data centers. AI gets the power it needs, communities get the jobs, and the grid stays strong.

Jack Pitcher (0:18)

Hey, listeners, it's Saturday, January 17th. I'm Jack Pitcher for The Wall Street Journal, and this is What's News in Markets, our look at the biggest stock moves of the week and the news that drove them. Let's get to it. Calm in the face of chaos. That was the theme for Markets this week. On Sunday night, news broke that Federal Reserve Chair Jerome Powell is being investigated by US prosecutors over his testimony about the Central Bank's building renovation project. In a video statement, Powell, who is usually quite restrained, called the investigation a pretext as part of President Trump's campaign to pressure the Fed to lower interest rates and in the independence of the Central Bank. Investors concerned that a lack of Fed independence could lead to runaway inflation have been closely watching the Powell situation. Meanwhile, banks kicked off earnings season with a mixed bag of results. JPMorgan disappointed investors with lower than expected investment banking revenue, but Goldman Sachs and Morgan Stanley posted strong quarters. At the index level, stocks inched lower for the week. The S&P 500 ended down 0.4% just shy of a record high. The Dow fell 0.3% while the Nasdaq Composite was 0.7% lower. Novo Nordisk's shares jumped in the US on Friday after a string of positive news about its flagship weight loss drug, Wigovie. The UK's health regulator approved a significantly higher dose of the drug for patients with a body mass index of at least 30 The Danish drugmaker is awaiting regulatory approvals for the same size dose in the US and the EU. Meanwhile, sales of Novo's Wigovie pill just began in the US. Data released Friday showed the new pill generated more than 4,000 new prescriptions in the US last week. A strong start, analysts said. Novo's American depository receipts jumped 9% Friday and closed up 6% for the week.

AI is causing investor angst over the outlook for some major software companies. Intuit, the maker of TurboTax, Salesforce, a corporate software titan, and Adobe, which makes Photoshop and Acrobat, were all among the worst performers in the S&P 500 this week. None of the companies reported specific bad news, but analysts say rapid advancements in AI are creating a general sense of unease around software companies that were once thought to be invincible thanks to the widespread adoption of their products. AI is becoming very adept at coding software. Some investors now picture a future in which companies can use AI to handle tasks, once outsourced to enterprise software, or simply build their own. For the week, Intuit shares fell 16 percent. Salesforce was 13 percent lower, while Adobe dropped 11 percent. The world's biggest investment firm keeps getting bigger. BlackRock reported a record 14 trillion in assets under management on Thursday, and investors were pleased with fee growth that beat expectations. BlackRock primarily makes money through fees at charges to manage trillions of dollars for clients. Its assets grew to a record in 2025 on the back of market gains and $700 billion of new client money. BlackRock shares advanced almost 6 percent after it reported earnings Thursday and closed the week near a record high. And now you know What's News in Markets this week. You can read more about the week's market moves on wsj.com. Today's show is produced by Jess Fenton with supervising producer Melanie Roy. I'm Jack Pitcher. Have a great weekend.

SPEAKER_3 (4:09)

Still running global payroll like a relay race? Deal replaces fragmented payroll vendors with one global system, no third parties. Hire and pay teams in 130 plus countries with in-house local experts and white glove delivery. And deal plugs into what you already use, Workday, SAP, NetSuite. Operate like a local, everywhere. Visit deel.com/wsj. That's deel.com/wsj.

Thousands of transcripts fetched by people building searchable podcast archives

Fetch the whole transcript

The demo key returns a sample episode in full, no card needed:

request
curl -H "x-api-key: pt_demo" \
  https://spoken.md/transcripts/1000651996090

Markdown with the speakers named, for your notes, your knowledge base, or anything that makes HTTP calls.

From $0.10 per transcript. No subscription. Credits never expire. Prices exclude VAT, added at checkout for EU customers. Not what you expected? Email us within 14 days with 20 or fewer credits used and we refund the pack in full.

Using your own key:

request
curl -H "x-api-key: YOUR_KEY" \
  https://spoken.md/transcripts/1000745533549